Large-scale testing (Phase 3)Study completedNCT01463683What this trial is testingModified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)Who this might be right forHepatitis B Merck Sharp & Dohme LLC 722
Early research (Phase 1)Study completedNCT02094729What this trial is testingA Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Eisai Co., Ltd. 26
Large-scale testing (Phase 3)Study completedNCT03189745What this trial is testingEvaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered).Who this might be right forMeningococcal ACWY Disease Pfizer 229
Large-scale testing (Phase 3)UnknownNCT02658409What this trial is testingA Multicenter, Double-blind, Parallel, Non-inferiority, Phase III StudyWho this might be right forInfluenza Green Cross Corporation 1,630
Early research (Phase 1)Study completedNCT03676101What this trial is testingEvaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy FemalesWho this might be right forCervical CancersVulvar CancerVaginal Cancer+12 more Shanghai Bovax Biotechnology Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT04527081What this trial is testingStudy of COVID-19 DNA Vaccine (AG0302-COVID19)Who this might be right forCOVID-19 AnGes, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02691130What this trial is testingAssess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in AdultsWho this might be right forInfluenzaHealthy BiondVax Pharmaceuticals ltd. 224
Early research (Phase 1)Study completedNCT00479999What this trial is testingPhase 1 Safety Study of Two Experimental HIV VaccinesWho this might be right forAIDS VaccinesHIV InfectionsHIV-1 National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT07155499What this trial is testingA Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.Who this might be right forRhinitis, Allergic, Seasonal AO GENERIUM 150
Large-scale testing (Phase 3)Study completedNCT03885934What this trial is testingSafety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024)Who this might be right forPneumococcal Infections Merck Sharp & Dohme LLC 606
Large-scale testing (Phase 3)Study completedNCT03095599What this trial is testingSeasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3Who this might be right forInfluenza, Human Institute of Vaccines and Medical Biologicals, Vietnam 889
Testing effectiveness (Phase 2)Study completedNCT01142765What this trial is testingStudy to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAPWho this might be right forMalaria University of Oxford 52
Testing effectiveness (Phase 2)Study completedNCT00319592What this trial is testingA Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAXWho this might be right forJapanese Encephalitis Sanofi 60
Testing effectiveness (Phase 2)Study completedNCT05198063What this trial is testingZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic ImmunizationWho this might be right forPrevention of COVID-19 Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Large-scale testing (Phase 3)Study completedNCT05044195What this trial is testingA Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of AgeWho this might be right forInfluenza, Human Seqirus 2,044
Post-approval studies (Phase 4)UnknownNCT05373030What this trial is testingSequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 VaccineWho this might be right forImmunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization Zhejiang Provincial Center for Disease Control and Prevention 200
Large-scale testing (Phase 3)UnknownNCT05156528What this trial is testingEfficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 YearsWho this might be right forDysenteryShigellosis Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 21,000
Testing effectiveness (Phase 2)Study completedNCT01084863What this trial is testingEvaluate Safety, Efficacy and PharmacokineticsWho this might be right forMetastatic Breast Cancer Celltrion 143
Testing effectiveness (Phase 2)Study completedNCT01013675What this trial is testingImmunogenicity and Safety of a Cell-derived Influenza Vaccine in ElderlyWho this might be right forInfluenza Vaccines Abbott Biologicals 622
Very early researchStudy completedNCT04818801What this trial is testingSafety, Reactogenicity and Immunogenicity Study of ReCOVWho this might be right forCovid19 Jiangsu Rec-Biotechnology Co., Ltd. 100